In Nature this week: multi-omic neuroscience quantitative trait locus resource, and more.
Researchers report that humans appear to be continuing to evolve, according to Newsweek.
Stat News reports that IBM's Watson for Oncology isn't yet living up to its promise.
Efforts to boost the number of women in science might not be working because they don't address the reasons why women leave, according to Salon.
In Genome Biology this week: heritable DNA methylation in Arabidopsis, genetic networks linked to agronomical traits in soybean, and more.
An investigative piece from the New York Times and ProPublica highlights concerns with DNA testing at the chief medical examiner office in New York.
Some researchers are using Freedom of Information Act requests to obtain copies of others' grant proposals, Buzzfeed News reports.
Scientific American writes that cell-free DNA-based tests could someday be used to uncover a range of diseases.
In PNAS this week: trait prediction algorithm, missense mutation linked to hearing loss, and more.
The island nation's government says it was not notified about controversial experiments taking place within its borders to develop a herpes vaccine.
Homology Medicines says it can edit genes without using CRISPR, Technology Review says, but some scientists are skeptical.
Though many biomedical facilities prepared well for Hurricane Harvey, scientists in other states are offering to help their Texas brethren who didn't fare so well.
In Science this week: a compound that appears to regulate a genetic risk factor for Parkinson's disease, and more.
A large majority of top federal science positions are empty, says the Center for Investigative Reporting.
Maria Jasin and her colleagues argue that the results of a Nature paper reporting a gene mutation correction in an embryo using CRISPR must be directly verified.
A Stanford professor says postdocs should be allowed to take their projects with them when they leave their PIs' labs to start their own endeavors.
In Nature this week: a new high-throughput approach for single-nucleus RNA sequencing, and more.
Stanford University School of Medicine has launched an online computer game to design an RNA molecule capable of acting as an on/off switch for CRISPR/Cas9.
A group of rich libertarians and a US university are supporting a vaccine trial offshore in what critics say is an end-run around safety protocols.
The pharmaceutical company is the first among its competitors to have a CAR-T cell therapy approved by the FDA, Marketwatch reports.
In Nucleic Acids Research this week: microRNAs in peripheral blood samples, circadian pacemaker components in the brain's suprachiasmatic nuclei, and more.
A review of available DNA ancestry testing kits by The Wirecutter has crowned Ancestry.com's kit the best on the market for those curious about their roots.
Gilead Sciences' recent acquisitions of Kite Pharma signals that genetic engineering is the next big thing for cancer therapy, according to Technology Review.
Organs-on-a-chip technology could be the next big boost for personalized medicine, The Scientist says.
In PNAS this week: getting a glimpse at the microbes in the human body, characterizing giant enteric symbionts in the guts of a marine surgeonfish, and more.
A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.
Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.
CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.
Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.